Results Presented From Asian and European Studies of Sirtex Microspheres

June 5, 2017—Sirtex Medical Limited announced that a head-to-head study has shown that selective internal radiation therapy (SIRT) with the company’s Sir-Spheres yttrium-90 (Y-90) resin microspheres, administered once directly to the liver, offers important benefits compared with twice-daily oral doses of sorafenib, the current standard of care for advanced hepatocellular carcinoma (HCC). Results of the…

Details